Innovating Works
PoC4ProMis: Preclinical in vivo proof-of-concept for cyclic oligopeptide rescuers of pathogenic protein misfoldi... RESQ BIOTECH IDIOTIKI KEFALAIOUCHIKI ETAIREIA tramitó un HORIZON EUROPE: ERC-2023-POC Within the ERC Consolidator Grant ProMiDis, my team and I have developed genetically engineered bacteria that function as a stand-alone, liv...
2024-09-01 - 2026-02-28 | Financiado
PoC4ProMis: Preclinical in vivo proof of concept for cyclic oligopeptide rescuers of pathogenic protein misfoldi... RESQ BIOTECH IDIOTIKI KEFALAIOUCHIKI ETAIREIA tramitó un HORIZON EUROPE: ERC-2023-POC Within the ERC Consolidator Grant ProMiDis, my team and I have developed genetically engineered bacteria that function as a stand-alone, liv...
2024-07-30 - 2026-02-28 | Financiado
ProMisMe: Bioengineered microbes as a platform for discovering chemical rescuers of disease-related misfolding... RESQ BIOTECH IDIOTIKI KEFALAIOUCHIKI ETAIREIA participó en un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-04 Protein misfolding diseases (PMDs) are a large group of human disorders caused by the misfolding of specific proteins. They include conditio...
2023-10-19 - 2026-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.